AU8222075A - Pyrimidine sulfonamides - Google Patents

Pyrimidine sulfonamides

Info

Publication number
AU8222075A
AU8222075A AU82220/75A AU8222075A AU8222075A AU 8222075 A AU8222075 A AU 8222075A AU 82220/75 A AU82220/75 A AU 82220/75A AU 8222075 A AU8222075 A AU 8222075A AU 8222075 A AU8222075 A AU 8222075A
Authority
AU
Australia
Prior art keywords
alkyl
formula
cycloalkyl
physiologically acceptable
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU82220/75A
Other languages
English (en)
Inventor
Harry Allen Albrecht
John Thomas Plati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU8222075A publication Critical patent/AU8222075A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/18—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/26—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU82220/75A 1974-06-19 1975-06-18 Pyrimidine sulfonamides Expired AU8222075A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US480784A US3923792A (en) 1974-06-19 1974-06-19 Sulfacytosine derivatives

Publications (1)

Publication Number Publication Date
AU8222075A true AU8222075A (en) 1976-12-23

Family

ID=23909351

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82220/75A Expired AU8222075A (en) 1974-06-19 1975-06-18 Pyrimidine sulfonamides

Country Status (20)

Country Link
US (1) US3923792A (enExample)
JP (1) JPS5113781A (enExample)
AU (1) AU8222075A (enExample)
BE (1) BE830360A (enExample)
DD (1) DD118090A5 (enExample)
DE (1) DE2526795A1 (enExample)
DK (1) DK274575A (enExample)
ES (1) ES438661A1 (enExample)
FI (1) FI751786A7 (enExample)
FR (1) FR2275218A1 (enExample)
GB (1) GB1471399A (enExample)
HU (1) HU170013B (enExample)
IE (1) IE41563B1 (enExample)
IL (1) IL47500A0 (enExample)
LU (1) LU72748A1 (enExample)
NL (1) NL7507154A (enExample)
NO (1) NO752174L (enExample)
PL (1) PL95005B1 (enExample)
SE (1) SE7506907L (enExample)
ZA (1) ZA752558B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54106635A (en) * 1978-01-30 1979-08-21 Mo Tekusuchiruni I Apparatus for separating fiber and supplying said fiber into spinning chamber
IL92096A0 (en) 1988-10-25 1990-07-12 Abbott Lab Carboxylic nucleoside analogs
US5153352A (en) * 1988-10-25 1992-10-06 Bristol-Myers Squibb Company Process for preparation of intermediates of carbocyclic nucleoside analogs
US5246931A (en) * 1988-10-25 1993-09-21 Bristol-Myers Squibb Company Carbocyclic nucleoside analogs
US4988703A (en) * 1989-05-22 1991-01-29 Abbott Laboratories Carbocyclic nucleoside analogs with antiviral activity
DE69230349T2 (de) * 1991-03-05 2000-07-27 Ajinomoto Co., Inc. Cyclopropanderivat
US7973060B2 (en) * 2005-10-13 2011-07-05 Crystalgenomics, Inc. Fab I inhibitor and process for preparing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3422098A (en) * 1962-12-14 1969-01-14 Ciba Geigy Corp Sulfanilamido-pyrimidines
US3457278A (en) * 1964-10-15 1969-07-22 Geigy Chem Corp Cyclopropyl-4-sulfanilamido-pyrimidines
US3375247A (en) * 1965-08-02 1968-03-26 Parke Davis & Co Heterocyclic compounds and methods for their production

Also Published As

Publication number Publication date
NL7507154A (nl) 1975-12-23
ZA752558B (en) 1976-03-31
DD118090A5 (enExample) 1976-02-12
JPS5113781A (enExample) 1976-02-03
FR2275218A1 (fr) 1976-01-16
IE41563B1 (en) 1980-01-30
US3923792A (en) 1975-12-02
SE7506907L (sv) 1975-12-22
DE2526795A1 (de) 1976-01-08
ES438661A1 (es) 1977-03-01
HU170013B (enExample) 1977-03-28
DK274575A (da) 1975-12-20
IL47500A0 (en) 1975-08-31
PL95005B1 (enExample) 1977-09-30
GB1471399A (en) 1977-04-27
IE41563L (en) 1975-12-19
FI751786A7 (enExample) 1975-12-20
LU72748A1 (enExample) 1976-11-11
BE830360A (fr) 1975-12-18
NO752174L (enExample) 1975-12-22

Similar Documents

Publication Publication Date Title
JPS5183277A (en) Ea fuirutano ryuryoseigyosochi
ZA756410B (en) Phenyl pyrimidines
JPS56108476A (en) Two knuckleehinge
AU8330675A (en) Pyrimidine derivatives
GB1517972A (en) 6-methyl-8alpha-cyanomethylergoline i
JPS51128437A (en) Useful nnsubstituted pyridon
IL48557A0 (en) Substituted ureido-compounds
ZA752558B (en) Sulfonamides
JPS5120252A (en) Yokatsubuzai narabini sonoseizohoho
CS324775A2 (en) Zpusob vyroby ferromagnetickeho kyslicniku chromiciteho
US3992538A (en) Substituted o-acyl-acrylaldoximes
ZA752007B (en) Substituted triphenylethylenes
HU172733B (hu) Rentgenovskij apparat
AU7835575A (en) Substituted diaminoguanidines
IL47587A (en) Substituted 1-sulfonylbenzimidazoles
PH14544A (en) Substituted tetrahydrobenzothiophenes
AU8293175A (en) Substituted hydroxyphenyl-piperidones
IL47350A0 (en) Substituted phenylmercapto-benzimidizoles
ZA75540B (en) Antiviral agents
JPS5110138A (en) Denkikamisorino ha
ZA754165B (en) Substituted 1-sulfonylbenzimidazoles
GB1506928A (en) Substituted poly-1-vinylpyrenes
JPS5159823A (en) * chiono * * ji * chioorurinsan * hosupponsan * esuteruoyobiesuteruuamidono seizohoho
JPS5115201A (en) Kaitenhonpuniokeru isoryutaihaishutsusochi
CA37482S (en) Plane